Serum ferritin ≥1,500 ng/ml was identified as an independent predictor for RP-ILD and a poor prognostic risk factor of anti-MDA5 Ab+ DM/CADM patients (15). This evidence concerns the gene IFIH1 and clinically amyopathic dermatomyositis.